Children younger than 5 years are the only age group in the United States not eligible for COVID-19 vaccination
Three-Dose Pfizer Vaccine Spurs Strong Response in Youngest Children
Company says third dose gave the young children 80 percent protection against asymptomatic COVID-19
Global Burden of RSV Profiled in Children Aged 0 to 60 Months in 2019
In 2019, 2.0 and 3.6 percent of deaths in children aged 0 to 60 months and 28 days to 6 months, respectively, attributable to RSV infection
Mystery of Pediatric Hepatitis Cases Deepens as CDC Probe Continues
One more U.S. death related to pediatric hepatitis was reported on Thursday
CDC Advisers Recommend Pfizer Booster Shot for Children 5 to 11
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
Preexisting Cardiovascular Conditions Tied to Severe COVID-19 in Children
Risk varies considerably across 26 examined cardiovascular conditions
FDA Authorizes Pfizer Booster Shot for Children Ages 5 to 11 Years
Third shot can be given at least five months after healthy children complete the two-dose vaccine series
Vaccine Effectiveness Modest for Children, Teens During Omicron
BNT162b2 vaccine effectiveness against symptomatic infection modest and declined rapidly, was higher after booster dose in teens
50-µg mRNA-1273 Safe, Effective for Children Aged 6 to 11 Years
Estimated vaccine efficacy with two doses was 88.0 percent against COVID-19 at a time when delta was dominant circulating variant
Only One in Five Parents Plan to Get COVID-19 Vaccine for Children Under 5 When Available
27 percent said they would ‘definitely not’ get their child vaccinated, 11 percent said they would do so only if required